USANA Q1 2026 EPS down 16% YoY to $0.41; reaffirms FY guidance

USANA HEALTH SCIENCES INC

2026-Q1 EPS reported $0.41 revenue$250,218,000

Net sales $250M flat YoY; net earnings $7.5M (-20%); diluted EPS $0.41 vs $0.49.
Adjusted diluted EPS $0.61 vs $0.73; adjusted EBITDA $28.4M (-5%).
Core Nutritional active customers 404,000 (-12%); Hiya active subscribers 186,000 (-17%).
Rise Wellness net sales $14M (+741%) from Costco nationwide launch.
Reiterates FY2026 outlook: consolidated net sales $925M–$1.0B; adjusted EPS $1.95–$2.29.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

USANA HEALTH SCIENCES INC reported first quarter ended April 4, 2026 results: revenue $250 million, net income $7.5 million, EPS $0.41. Guidance reaffirmed.

Period: first quarter ended April 4, 2026
Revenue: $250 million
Net income: $7.5 million
EPS: $0.41
Guidance: reaffirmed
Result: reported results

Exact text from the filing

(NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026. Key Financial Results First Quarter 2026 vs. First Quarter 2025 • Net sales of $250 million versus $250 million. • Net earnings of $7.5 million versus $9.4 million. • Diluted EPS of $0.41 as compared with $0.49. • Adjusted diluted EPS (1) of $0.61 as compared with

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

USANA HEALTH SCIENCES INC filing history →

Source: SEC EDGAR

accession 0000896264-26-000030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.